We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBO Reports on Drugmaker Promotional Expenses for Detailing, Direct-to-Consumer and Other Venues
CBO Reports on Drugmaker Promotional Expenses for Detailing, Direct-to-Consumer and Other Venues
December 4, 2009
The Congressional Budget Office (CBO) has released a report saying some types of drug promotions may lead doctors to prescribe brand-name products more
than generic alternatives, just days before the House Energy and Commerce Committee scheduled a hearing on prescription drug price inflation.